Litcius/Paper detail

Design, synthesis, and biological evaluation of 1-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea derivatives as anticancer agents

Ayoub Aghcheli, Mahsa Toolabi, Adileh Ayati, Setareh Moghimi, Loghman Firoozpour, Tayebeh Oghabi Bakhshaiesh, Elahe Nazeri, Maryam Norouzbahari, Rezvan Esmaeili, Alireza Foroumadi

2020Medicinal Chemistry Research30 citationsDOI

Topics & Concepts

HeLaChemistryApoptosisCell cycleIn silicoCytotoxicityCancer cellFlow cytometrySorafenibIn vitroIC50Docking (animal)Cell cultureStereochemistryCell growthPharmacologyCancerBiochemistryCancer researchMolecular biologyBiologyGeneticsGeneMedicineNursingHepatocellular carcinomaSynthesis and biological activityQuinazolinone synthesis and applicationsSynthesis and Biological Evaluation
Design, synthesis, and biological evaluation of 1-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea derivatives as anticancer agents | Litcius